Coronary atherosclerosis
Clinical trials for Coronary atherosclerosis explained in plain language.
Never miss a new study
Get alerted when new Coronary atherosclerosis trials appear
Sign up with your email to follow new studies for Coronary atherosclerosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug YN001 aims to shrink artery plaque in heart disease trial
Disease control Recruiting nowThis study tests a drug called YN001 in 456 adults with coronary atherosclerosis (plaque buildup in heart arteries). Participants receive weekly injections of YN001 or a placebo for 13 weeks. The main goal is to see if YN001 reduces plaque volume in the arteries, as measured by a…
Matched conditions: CORONARY ATHEROSCLEROSIS
Phase 2 • Sponsor: Beijing Inno Medicine Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 04:00 UTC
-
A sharper MRI lens for hidden heart danger
Diagnosis Recruiting nowThis study is testing a new MRI technique called CATCH to improve how doctors evaluate coronary atherosclerosis—the buildup of plaque in heart arteries. The goal is to make the scan faster, simpler, and more reliable than current methods, especially for identifying 'hot spots'—pl…
Matched conditions: CORONARY ATHEROSCLEROSIS
Sponsor: Cedars-Sinai Medical Center • Aim: Diagnosis
Last updated Aug 23, 2026 00:00 UTC
-
New CT scans reveal Statins' secret effect on heart plaque
Knowledge-focused Recruiting nowThis study looks at how a short course of high-dose statins affects fatty buildup (plaque) in the heart arteries of people with mild heart disease. Researchers will use advanced CT scans to measure changes in plaque size and type over 3 months, and then check if those changes las…
Matched conditions: CORONARY ATHEROSCLEROSIS
Sponsor: Prof. Maurovich-Horvat Pál • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC